(a) A pharmacist, in good faith, may provide ivermectin to a patient who is eighteen (18) years of age or older pursuant to a valid collaborative pharmacy practice agreement containing a non-patient-specific prescriptive order and standardized procedures developed and executed by one (1) or more authorized prescribers.

Terms Used In Tennessee Code 63-10-224

  • Board: means the Tennessee board of pharmacy. See Tennessee Code 63-10-204
  • Collaborative pharmacy practice agreement: is a written and signed agreement entered into voluntarily between one (1) or more licensed pharmacists in this state, and one (1) or more prescribers licensed in this state, each of whom is in active practice in this state providing patient care services in this state, that provides for collaborative pharmacy practice, as defined by law. See Tennessee Code 63-10-204
  • Dispense: means preparing, packaging, compounding or labeling for delivery and actual delivery of a prescription drug, nonprescription drug or device in the course of professional practice to a patient or the patient's agent, to include a licensed health care practitioner or a health care facility providing services or treatment to the patient or patients, by or pursuant to the lawful order of a prescriber. See Tennessee Code 63-10-204
  • Pharmacist: means an individual health care provider licensed by the state, pursuant to parts 4-6 of this chapter, to practice the profession of pharmacy. See Tennessee Code 63-10-204
  • Pharmacy: means a location licensed by this state where drugs are compounded or dispensed under the supervision of a pharmacist, as defined in the rules of the board and where prescription orders are received or processed. See Tennessee Code 63-10-204
  • Prescriber: means an individual authorized by law to prescribe drugs. See Tennessee Code 63-10-204
(b) The pharmacist shall maintain the collaborative pharmacy practice agreement in accordance with § 63-10-217.
(c) The board of pharmacy shall adopt rules to establish standard procedures for the provision of ivermectin by pharmacists, including:

(1) Providing the patient with a screening risk assessment tool;
(2) Providing the patient with a standardized factsheet that includes, but is not limited to, the indications and contraindications for use of ivermectin, the appropriate method for using ivermectin, the importance of medical follow-up, and other information deemed appropriate by the board; and
(3) Either dispensing the ivermectin or referring the patient to a pharmacy that may dispense the medication as soon as practical.
(d) A pharmacist, pharmacist’s employer, or pharmacist’s agent may charge an administrative fee for services provided pursuant to this section in addition to costs associated with the dispensing of ivermectin and paid by the pharmacy benefit.
(e) A pharmacist or prescriber acting in good faith and with reasonable care involved in the provision of ivermectin pursuant to this section is immune from disciplinary or adverse administrative actions under this title for acts or omissions during the provision of ivermectin.
(f) A pharmacist or prescriber involved in the provision of ivermectin pursuant to this section is immune from civil liability in the absence of gross negligence or willful misconduct for actions authorized by this section.
  Previous section
Next section  
 Part 2 Contents